GWM
ANIP icon

Gupta Wealth Management’s ANI Pharmaceuticals ANIP Stock Holding History

Gupta Wealth Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$1K Hold
16
– – ﹤0.01% 1103
2015
Q4 		$1K Hold
16
– – ﹤0.01% 1168
2015
Q3 		$1K Hold
16
– – ﹤0.01% 1179
2015
Q2 		$1K Hold
16
– – ﹤0.01% 1183
2015
Q1 		$1K Buy
+16
New +$973 ﹤0.01% 1079

Other funds holding ANIP

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return

Gupta Wealth Management's ANIP Position: Q1 2016 in Review

Gupta Wealth Management held its ANI Pharmaceuticals (ANIP) position steady in Q1 2016 at 16 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #1103.

Gupta Wealth Management first reported a position in ANIP in Q1 2015 and has held it in 5 quarters since. 121 funds tracked by Wall St. Rank hold ANIP as of Q1 2016.

  • Gupta Wealth Management held 16 shares of ANI Pharmaceuticals worth $1K as of Q1 2016.
  • Gupta Wealth Management left its ANI Pharmaceuticals share count unchanged in Q1 2016.
  • ANI Pharmaceuticals made up ﹤0.01% of Gupta Wealth Management's portfolio in Q1 2016, its #1103 holding.
  • Gupta Wealth Management first reported a position in ANI Pharmaceuticals in Q1 2015 and has held it in 5 quarters since.
  • 121 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2016.

Based on Gupta Wealth Management's 13F filing for Q1 2016, filed 16 May 2016.